Delivery Order SPE2DB22D3501-SPE2DB25FWE43
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Spravato 84 mg dose pack unit dose systems, with a ceiling value of $11,110.02. This firm fixed price delivery order is scheduled for completion by October 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition without a set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,904.65 on May 27, 2025, for the supply of Spravato 84 mg dose pack unit dose systems (UDS). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of May 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Spravato is an FDA-approved nasal spray medication primarily used for treatment-resistant depression, making this a specialized...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,829.09 to AmerisourceBergen Drug Corp for the supply of SPRAVATO 84 mg dose pack UDS (unit dose packages). This firm fixed price delivery order, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. SPRAVATO (esketamine) is a prescription nasal spray used in treating...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of SPRAVATO 84 MG DOSE PACK medical supplies. The order, valued at $22,963.32, has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which was not set aside for any specific business type. Amerisourcebergen Drug Corp also...
- This is a $8,028.33 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The contract is for the supply of SPRAVATO 84 MG DOSE PACK medical products. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPRAVATO 84 MG DOSE PACK UDS. The contract has a firm fixed price of $8,057.79 and an ultimate completion date of July 30, 2024. The contract is not designated as a set-aside award. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,701.79, is for the supply of SPRAVATO 84 MG DOSE PACK UDS, a specialty medication. The contract is a Firm Fixed Price arrangement with a period of performance through November 13, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award, valued at $1,283.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPRAVATO 56 MG DOSE PACK UDS, a medical product, and has an ultimate completion date of February 26, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,622.08 contract is for the supply of SPRAVATO 84 MG DOSE PACK UDS, a specialty medication. The contract has a period of performance through September 13, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, such as a $999,999,999 DLA Troop Support Medical IDC and a $750,000...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,860.83 firm-fixed-price delivery order is for SPRAVATO 84 MG DOSE PACK UDS, a medication, with an ultimate completion date of July 11, 2025. This contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWE43Delivery Order
The Defense Logistics Agency awarded a $5,635.88 delivery order to AmerisourceBergen Drug Corp for Spravato 84 mg dose pack unit dose systems on June 26, 2025, with an ultimate completion date of June 27, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Spravato is a specialized neuropsychiatric medication, reflecting the breadth of pharmaceutical products that AmerisourceBergen supplies through federal procurement channels. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving military and federal healthcare systems, AmerisourceBergen holds a strategic position in the Department of Defense's medical supply chain. The company supplies an extensive portfolio of medications, vaccines, and medical devices across multiple therapeutic areas to support Defense Health Agency operations and other government healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 6/26/25 |